Canada Pension Plan Investment Board purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 241,800 shares of the company's stock, valued at approximately $2,394,000.
Several other institutional investors have also modified their holdings of the company. BlackRock Inc. bought a new stake in Avantor in the 2nd quarter valued at about $695,784,000. Wellington Management Group LLP acquired a new position in Avantor during the 4th quarter valued at about $268,584,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in Avantor in the 2nd quarter worth about $195,386,000. Morgan Stanley grew its position in Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock worth $200,188,000 after purchasing an additional 11,216,565 shares during the last quarter. Finally, Engine Capital Management LP increased its stake in shares of Avantor by 65.8% in the first quarter. Engine Capital Management LP now owns 19,780,830 shares of the company's stock valued at $155,082,000 after purchasing an additional 7,853,018 shares during the period. Institutional investors own 95.08% of the company's stock.
Wall Street Analysts Forecast Growth
AVTR has been the topic of a number of recent analyst reports. Sanford C. Bernstein assumed coverage on Avantor in a report on Friday, June 26th. They set a "market perform" rating and a $10.50 price target on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $13.00 price objective on shares of Avantor in a report on Thursday, July 30th. Royal Bank Of Canada raised their target price on Avantor from $9.00 to $14.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Jefferies Financial Group raised Avantor from an "underperform" rating to a "hold" rating and set a $13.00 target price on the stock in a research note on Wednesday, July 29th. Finally, Citigroup boosted their price target on Avantor from $9.00 to $11.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 8th. Two analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $12.00.
Read Our Latest Research Report on AVTR
Avantor Stock Up 0.1%
AVTR stock opened at $14.60 on Monday. The firm's 50-day moving average is $12.12 and its two-hundred day moving average is $9.76. The company has a market capitalization of $9.87 billion, a price-to-earnings ratio of -17.38, a price-to-earnings-growth ratio of 11.00 and a beta of 0.89. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65.
Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.61 billion. During the same period last year, the firm posted $0.24 earnings per share. The business's revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, analysts forecast that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.
Avantor Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Read More
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.